SCHEMBL18974754

SCHEMBL18974754

O=C1C(=O)N(Cc2ccccc2O)c2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 2/20 0.61
CES1 P23141 7/20 0.61
ALDH1A1 P00352 4/20 0.61
ALDH3A1 P30838 4/20 0.61
CHRM1 P11229 2/20 0.61
ALDH2 P05091 2/20 0.61
BCHE P06276 4/20 0.59
ACHE P22303 2/20 0.58
CES2 O00748 1/20 0.56
CHRM5 P08912 2/20 0.55
CHRM3 P20309 1/20 0.55
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
TP53 P04637 2/20 0.51
MAPT P10636 2/20 0.51
APAF1 O14727 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
ALOX15 P16050 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954691 0.82 TGM2 (0.68) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL18974327 0.81 CES1 (0.62) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL15624560 0.81 MPO (0.50) ALDH1A1MAPTCYP2D6ALOX15TSHR
SCHEMBL18954909 0.81 ALDH1A1 (0.71) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL15928248 0.81 TGM2 (0.75) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL4596020 0.81 TGM2 (0.61) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL5430327 0.81 CHRM1 (0.63) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL4609842 0.81 CES1 (0.66) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL28841898 0.81 CES1 (0.66) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL18954710 0.81 CA1 (0.76)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 WO disclosed